Norway, which has one of the highest deadly drug overdose rates in Europe, will test prescribing free heroin to the most serious addicts to improve their living conditions, the government said today.
The Norwegian Directorate for Health and Social Affairs has been tasked with proposing an experimental project to identify patients likely to benefit from the programme, to examine the implementation method, and to calculate the costs.
"We hope that this will provide a solution that will give... a better quality of life to some addicts who are today out of our reach and whom current programmes do not help enough," Health Minister Bente Hoie wrote on Facebook.
Norway has one of the highest overdose mortality rates in Europe, with 81 deaths per million in 2015 after Estonia (132 deaths per million) and Sweden (88 deaths per million), according to the European Monitoring Centre for Drugs and Drug Addiction.
Already adopted or tested in Switzerland, the Netherlands and Denmark, medical heroin therapy is controversial, but supporters argue that in addition to improving the quality of life of addicts and lowering overdose mortality, it reduces crime and the costs associated with it.
The first treatments under the project will begin in 2020 at the earliest, the health ministry said in a statement. The initiative could benefit up to 400 drug addicts, according to the daily Aftenposten.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
